Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache

OBJECTIVE: This post hoc analysis in patients medically diagnosed with chronic migraine (CM) and medication‐overuse headache (MOH) evaluated reductions in the use of acute headache medication (AHM) and sustained changes in the diagnostic status of CM and MOH following eptinezumab treatment in the PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Marmura, Michael J., Diener, Hans‐Christoph, Cowan, Robert P., Tepper, Stewart J., Diamond, Merle L., Starling, Amaal J., Hirman, Joe, Mehta, Lahar, Brevig, Thomas, Cady, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291601/
https://www.ncbi.nlm.nih.gov/pubmed/34551130
http://dx.doi.org/10.1111/head.14206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291601/
https://www.ncbi.nlm.nih.gov/pubmed/34551130
http://dx.doi.org/10.1111/head.14206

Ejemplares similares